secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2026-07-27T11:30:37+00:00
Accession:  0001628280-26-049665
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences promotes Alex Kelly to COO, names Naresh Tanna CFO effective Aug 1
--------------------------------------------------------------------------------

- Alex Kelly, former CFO, becomes COO overseeing customer-facing functions; salary raised to $510,000 with 45% bonus target.
- Naresh Tanna promoted from VP of IR and Chief of Staff to CFO; salary $400,000 with 40% bonus target.
- Mei Burris designated as principal accounting officer and Chief Accounting Officer effective Aug 1.
- Two new physician leaders hired under Chief Development Officer Cindy Atwell for PBGENE-HBV and PBGENE-DMD programs.
- Chief Scientific Officer Cassie Gorsuch now leads all research functions including translational sciences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000162828026049665/0001628280-26-049665-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000162828026049665/dtil-20260723.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-049665

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer